TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency. December 19, 2008
TCL Archive In Brief: Shingleton Probably Replacement For Marks On Panel; Connie Henke Heads Oncology Nurses June 8, 1979